Saint Luke's Mountain States Tumor Institute - Nampa — Nampa, Idaho

Saint Luke's Mountain States Tumor Institute - Nampa is a clinical research site located in Nampa, Idaho, United States 83686.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Saint Luke's Mountain States Tumor Institute - Nampa has participated in 48 clinical trials with 10 currently active.

Therapeutic areas: Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Radionecrosis.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nampa

Browse all research sites in Idaho · View every site in Nampa

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Mountain States Tumor Institute - Nampa?

Saint Luke's Mountain States Tumor Institute - Nampa has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Mountain States Tumor Institute - Nampa conducted?

Saint Luke's Mountain States Tumor Institute - Nampa has 48 clinical trials on record, with 10 currently active. Their work covers Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Radionecrosis.

Is Saint Luke's Mountain States Tumor Institute - Nampa accredited by Crixeo Clinical Trials?

Saint Luke's Mountain States Tumor Institute - Nampa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's Mountain States Tumor Institute - Nampa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.